Navigation Links
Covance Elects Dr. Gary E. Costley to Board of Directors
Date:9/27/2007

PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it has elected Dr. Gary E. Costley to its Board of Directors.

Dr. Costley adds further executive management experience to the Covance Board of Directors, as well as extensive scientific depth in nutritional chemistry, food safety and drug discovery services. He was Chairman and Chief Executive Officer of International Multifoods Corporation, manufacturer of branded consumer food and foodservice products. He also spent 25 years at the Kellogg Company in roles of increasing global responsibility in the areas of nutrition research and product development, public affairs and executive management. Dr. Costley is a co-founder and currently managing director of C&G Capital Management, LLC, which provides capital and management to health, medical and nutritional products and services companies.

Dr. Costley is a board member for three other public companies: Prestige Brand Holdings, Inc., a company that develops and markets over-the-counter drugs, household cleaning products and personal care items; Principal Financial Group, Inc., a financial and asset management company; and Tiffany and Co., a holding company for Tiffany and Company, a jewelry and specialty retailer. He also previously held board memberships in Accelrys, Inc. and Pharmacopeia Drug Discovery, Inc., organizations specializing in products and services that improve and accelerate drug discovery and chemical development.

"I am very pleased to welcome Dr. Gary Costley to the Covance Board of Directors. Dr. Costley's successful track record in leading global public companies brings tremendous value to Covance's board," said Joe Herring, Covance Chairman and Chief Executive Officer. "His strong scientific background in food product development and nutrition research will also enhance Covance's ability to respond to the increasing global demand for food safety testing."

Dr. Costley earned a B.S. in animal science, and a M.S. and Ph.D. in Nutrition, with minors in Physiology and Biochemistry from Oregon State University.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,400 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woman Elects For Mastectomy: Prolonged Wait For Genetic Results
2. United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
3. Study casts doubt on keyboard ills
4. Who Board To Discuss Asian Tsunami Related Health Issues
5. Abdominal Crunches Not The Best Option For Wash Board Abs.
6. Computer Keyboards In Hospitals Could Spread Infection To Patients
7. Flu, Boarded A Ship?
8. Skateboarding to health
9. Shangai Citizens to Monitor Billboards
10. Budhia Is Fine, Government-constituted Medical Board Reports False
11. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: